NeuBase Therapeutics, Inc. (NBSE) News
Filter NBSE News Items
NBSE News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
Latest NBSE News From Around the Web
Below are the latest news stories about NEUBASE THERAPEUTICS INC that investors may wish to consider to help them evaluate NBSE as an investment opportunity.
Psychemedics Corporation Appoints Daniella Mehalik as VP - FinanceACTON, Mass., Nov. 27, 2023 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ: PMD), a global leader in hair testing for substance abuse, proudly announces the appointment of Daniella Mehalik as its new Vice President - Finance. In her new role, Ms. Mehalik will assume responsibility for directing and managing all financial activities at Psychemedics, including comprehensive oversight of external reporting and internal analysis. Reporting directly to CEO and President Brian Hullinger, she wil |
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on MondayIt's time to dive into the biggest pre-market stock movers as we start the trading week on Monday with the hottest coverage! |
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on ThursdayIt's time to start off Thursday with a breakdown of the biggest pre-market stock movers investors will want to watch this morning. |
NeuBase Therapeutics Issues Statement Regarding Filing By ShareholderPITTSBURGH, Sept. 08, 2023 (GLOBE NEWSWIRE) -- NeuBase Therapeutics, Inc. (Nasdaq: NBSE) (“NeuBase” or the “Company”) today issued the following statement regarding the Schedule 13D filed with the U.S. Securities and Exchange Commission on August 31, 2023, by Symetryx Corporation (“Symetryx”) and their subsequent press release issued on September 6, 2023. “The NeuBase Board of Directors (“Board”) appreciates input from its shareholders. The Board remains committed to completing its comprehensive |
Why Is NeuBase Therapeutics (NBSE) Stock Down 27% Today?NeuBase Therapeutics (NBSE) stock is dropping on Thursday but that's only due to the company coming off a massive rally yesterday. |
ChargePoint Layoffs 2023: What to Know About the Latest CHPT Job CutsChargePoint (CHPT) layoffs are in the news after the EV charging company announced job cuts alongside its latest earnings report. |
Why Is Dutch Bros (BROS) Stock Down 8% Today?Dutch Bros (BROS) stock is taking a beating on Thursday after the coffee chain announced an underwritten public offering for its shares. |
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on ThursdayWe're diving into the biggest pre-market stock movers as we check out all of the hottest news happening on Thursday morning! |
Why Is Marin Software (MRIN) Stock Up 34% Today?Marin Software (MRIN) stock is rising higher on Wednesday after the marketing software company announced the integration of HubSpot data. |
Why Is NeuBase Therapeutics (NBSE) Stock Up 19% Today?NeuBase Therapeutics (NBSE) stock is taking off on Wednesday despite a lack of news from the preclinical biopharmaceutical company. |